recovery trial covid | Dexamethasone in Hospitalized Patients with Cov

Keyword	CPC	PCC	Volume	Score	Length of keyword
recovery trial covid	0.85	0.8	7600	43	20
recovery	0.05	0.1	7497	67	8
trial	0.47	0.8	5992	77	5
covid	1.21	0.1	2049	50	5

Keyword	CPC	PCC	Volume	Score
recovery trial covid	1.18	0.8	6175	37
recovery trial covid-19	0.09	0.2	1422	30
recovery trial covid dexamethasone	0.23	1	6581	91
tocilizumab covid recovery trial	1.37	1	7828	59
recovery trial covid 19	1.64	0.2	3625	5
recovery trial long covid	1.68	0.6	3318	63
recovery trial steroids covid	0.87	0.6	7074	65

Search Results related to recovery trial covid on Search Engine

Dexamethasone in Hospitalized Patients with Covid-19
nejm.org

https://www.nejm.org/doi/full/10.1056/NEJMoa2021436

WEBJul 17, 2020 · The RECOVERY trial provides evidence that treatment with dexamethasone at a dose of 6 mg once daily for up to 10 days reduces 28-day mortality in patients with Covid-19 who are receiving ...

DA: 2 PA: 75 MOZ Rank: 33

Welcome — RECOVERY Trial
recoverytrial.net

https://www.recoverytrial.net/

WEBRECOVERY is an international clinical trial identifying treatments that may be beneficial for people hospitalised with pneumonia. RECOVERY started in the UK in early 2020 as the Randomised Evaluation of COVID-19 Therapy, a clinical trial testing treatments for people admitted to hospital with COVID-19 pneumonia.

DA: 6 PA: 68 MOZ Rank: 69

High-dose corticosteroid therapy in COVID-19: the RECOVERY trial
thelancet.com

https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(23)02884-2/fulltext

WEBApr 6, 2024 · High-dose corticosteroid therapy in COVID-19: the RECOVERY trial. The RECOVERY Collaborative Group trial evaluated the efficacy of high and low doses of the anti-inflammatory corticosteroid dexamethasone in patients hospitalised for COVID-19 receiving oxygen or no oxygen with less than 92% saturation in room air.

DA: 42 PA: 21 MOZ Rank: 26

The RECOVERY trial – UKRI - UK Research and Innovation
ukri.org

https://www.ukri.org/news-and-events/tackling-the-impact-of-covid-19/vaccines-and-treatments/recovery-trial-identifies-covid-19-treatments/

WEBMay 26, 2022 · The RECOVERY trial is the world’s largest clinical trial into treatments for COVID-19, with more than 40,000 participants across 185 trial sites in the UK. It was founded by UK Research and Innovation (UKRI)’s Medical Research Council (MRC) and the National Institute of Health Research (NIHR) with a joint investment of £2.1 million in ...

DA: 90 PA: 89 MOZ Rank: 44

NIH launches long COVID clinical trials through RECOVER …
nih.gov

https://www.nih.gov/news-events/news-releases/nih-launches-long-covid-clinical-trials-through-recover-initiative-opening-enrollment

WEBPfizer. Today, the National Institutes of Health launched and is opening enrollment for phase 2 clinical trials that will evaluate at least four potential treatments for long COVID, with additional clinical trials to test at least seven more treatments expected in the coming months. Treatments will include drugs, biologics, medical devices and ...

DA: 60 PA: 60 MOZ Rank: 68

Covid-19: The inside story of the RECOVERY trial | The BMJ
bmj.com

https://www.bmj.com/content/370/bmj.m2670

WEBJul 8, 2020 · Conducted by researchers at Oxford University, the ongoing Randomised Evaluation of Covid-19 Therapy (RECOVERY) trial involves all major hospitals in the UK on an unprecedented scale and as many as 3500 doctors, nurses, and research staff, including consultants, junior doctors, and those newly graduated.

DA: 95 PA: 22 MOZ Rank: 72

Higher dose corticosteroids in patients admitted to hospital …
thelancet.com

https://www.thelancet.com/pdfs/journals/lancet/PIIS0140-6736(23)00510-X.pdf

WEBThe randomised evaluation of COVID-19 therapy (RECOVERY) trial has previously shown that the use of corticosteroids (using dexamethasone 6 mg once daily for 10 days or until discharge if sooner) reduces the risk of death in patients admitted to hospital with COVID-19 and hypoxia. 1. Subsequent findings that additional

DA: 31 PA: 52 MOZ Rank: 6

RECOVERY 1 year on: a rare success in the COVID-19 clinical trial …
nature.com

https://www.nature.com/articles/d41573-021-00068-w

WEBApr 16, 2021 · RECOVERY 1 year on: a rare success in the COVID-19 clinical trial landscape. Peter Horby, co-lead on the RECOVERY platform trial, discusses the origins, lessons learned and future plans...

DA: 43 PA: 51 MOZ Rank: 40

The RECOVERY trial: An analysis and reflection two years on
nih.gov

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9511114/

WEBSep 26, 2022 · The RECOVERY trial led the way in scientific advances during the initial stages of the coronavirus disease 2019 (COVID-19) pandemic with regards to changing clinical practice [1,2]. This was a result of, among other things, a well-designed and simple trial protocol that allowed easy implementation during a time when healthcare was most ...

DA: 78 PA: 64 MOZ Rank: 62

Higher-dose dexamethasone for patients with COVID-19 and …
thelancet.com

https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(23)00587-1/fulltext

WEBApr 12, 2023 · Early in the COVID-19 pandemic, the RECOVERY trial showed that anti-inflammatory therapy with 6 mg daily dexamethasone improved survival in patients requiring oxygen supplementation.1 Additional anti-inflammatory therapy with either interleukin-6 (IL-6) inhibitors or the Janus kinase inhibitor baricitinib was later shown to provide further ...

DA: 27 PA: 65 MOZ Rank: 62